Immune tolerance for the treatment of factor VIII inhibitors - Twenty years' 'Bonn protocol'

被引：202
作者：
Brackmann, HH
Oldenburg, J
Schwaab, R
机构：
来源：
VOX SANGUINIS | 1996年 / 70卷
关键词：
D O I：
10.1111/j.1423-0410.1996.tb01346.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：30 / 35
页数：6
相关论文
共 7 条
[1]  
BRACKMANN HH, 1977, LANCET, V2, P933
[2]  
BRACKMANN HH, 1982, ACTIVATED PROTHROMBI, P45
[3]  
BRAY GL, 1994, BLOOD, V83, P2428
[4]   INCIDENCE OF DEVELOPMENT OF FACTOR-VIII AND FACTOR-IX INHIBITORS IN HEMOPHILIACS [J].
EHRENFORTH, S ;
KREUZ, W ;
SCHARRER, I ;
LINDE, R ;
FUNK, M ;
GUNGOR, T ;
KRACKHARDT, B ;
KORNHUBER, B .
LANCET, 1992, 339 (8793) :594-598
[5]   ACTIVATED PROTHROMBIN CONCENTRATE FOR PATIENTS WITH FACTOR-VIII INHIBITORS [J].
KURCZYNSKI, EM ;
PENNER, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (04) :164-167
[6]   RECOMBINANT FACTOR-VIII FOR THE TREATMENT OF PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A - SAFETY, EFFICACY, AND DEVELOPMENT OF INHIBITORS [J].
LUSHER, JM ;
ARKIN, S ;
ABILDGAARD, CF ;
SCHWARTZ, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (07) :453-459
[7]   HEMOPHILIA-A - DATABASE OF NUCLEOTIDE SUBSTITUTIONS, DELETIONS, INSERTIONS AND REARRANGEMENTS OF THE FACTOR-VIII GENE, 2ND EDITION [J].
TUDDENHAM, EGD ;
SCHWAAB, R ;
SEEHAFER, J ;
MILLAR, DS ;
GITSCHIER, J ;
HIGUCHI, M ;
BIDICHANDANI, S ;
CONNOR, JM ;
HOYER, LW ;
YOSHIOKA, A ;
PEAKE, IR ;
OLEK, K ;
KAZAZIAN, HH ;
LAVERGNE, JM ;
GIANNELLI, F ;
ANTONARAKIS, SE ;
COOPER, DN .
NUCLEIC ACIDS RESEARCH, 1994, 22 (17) :3511-3533
1